SCHEMBL964598

SCHEMBL964598

Cc1ccccc1-c1cccc(C(=O)C(C)(C)C)c1

nearest known ligand 0.53

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
NR1H4 Q96RI1 2/20 0.53
FFAR1 O14842 4/20 0.49
SMYD2 Q9NRG4 1/20 0.46
S1PR4 O95977 1/20 0.46
MCL1 Q07820 1/20 0.45
CNR1 P21554 1/20 0.45
HTR7 P34969 2/20 0.43
AKR1C3 P42330 1/20 0.43
AKR1C2 P52895 1/20 0.43
GRIN2B Q13224 1/20 0.42
CDK4 P11802 1/20 0.42
CCND1 P24385 1/20 0.42
EDNRB P24530 1/20 0.41
EDNRA P25101 1/20 0.41
FFAR4 Q5NUL3 2/20 0.40
RXRA P19793 1/20 0.40
RXRB P28702 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL964597 0.83 RXRA (0.39) NR1H4RXRARXRB
SCHEMBL14226712 0.83 KAT6A (0.50) AKR1C3AKR1C2CDK4CCND1
SCHEMBL2995452 0.81 NR1H4 (0.74) NR1H4FFAR1SMYD2S1PR4MCL1
SCHEMBL26054734 0.81 CA12 (0.46) NR1H4MCL1CDK4CCND1
SCHEMBL14226740 0.81 KMO (0.60) RXRARXRB
SCHEMBL13611931 0.80 NR1H4 (0.60) NR1H4FFAR1SMYD2S1PR4CNR1
SCHEMBL28452076 0.80 NR1H4 (0.59) NR1H4FFAR1SMYD2S1PR4MCL1
SCHEMBL27959627 0.80 NR1H4 (0.59) NR1H4FFAR1SMYD2S1PR4MCL1
SCHEMBL3636122 0.80 NR1H4 (0.56) NR1H4FFAR1SMYD2S1PR4MCL1
SCHEMBL735164 0.79 NR1H4 (0.55) NR1H4FFAR1SMYD2S1PR4MCL1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 13 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20110245238-A1 Novel Soluble 1,4 Benzodiazepine Compounds and Stable Salts Thereof THE REGENTS OF THE UNIVERSITY OF MICHIGAN (US) 2011-10-06 US claimed
US-20110009393-A1 Novel Soluble 1,4 Benzodiazepine Compounds and Stable Salts Thereof THE REGENTS OF THE UNIVERSITY OF MICHIGAN (US) 2011-01-13 US claimed
US-7759338-B2 Soluble 1,4 benzodiazepine compounds and stable salts thereof THE REGENTS OF THE UNIVERSITY OF MICHIGAN (US) 2010-07-20 US claimed
EP-2152080-A1 NOVEL SOLUBLE 1,4 BENZODIAZEPINE COMPOUNDS AND STABLE SALTS THEREOF The Regents of the University of Michigan (US) 2010-02-17 EP claimed
WO-2008133635-A1 NOVEL SOLUBLE 1,4 BENZODIAZEPINE COMPOUNDS AND STABLE SALTS THEREOF THE REGENTS OF THE UNIVERSITY OF MICHIGAN (US) 2008-11-06 WO claimed
US-20080064686-A1 Novel soluble 1,4 benzodiazepine compounds and stable salts thereof THE REGENTS OF THE UNIVERSITY OF MICHIGAN (US) 2008-03-13 US claimed
US-20120316105-A1 Polymyxin Derivates Useful As Antibacterial Agents PFIZER INC. 2012-12-13 US disclosed
US-20110245238-A1 Novel Soluble 1,4 Benzodiazepine Compounds and Stable Salts Thereof THE REGENTS OF THE UNIVERSITY OF MICHIGAN (US) 2011-10-06 US disclosed
US-20110009393-A1 Novel Soluble 1,4 Benzodiazepine Compounds and Stable Salts Thereof THE REGENTS OF THE UNIVERSITY OF MICHIGAN (US) 2011-01-13 US disclosed
US-7759338-B2 Soluble 1,4 benzodiazepine compounds and stable salts thereof THE REGENTS OF THE UNIVERSITY OF MICHIGAN (US) 2010-07-20 US disclosed
EP-2152080-A1 NOVEL SOLUBLE 1,4 BENZODIAZEPINE COMPOUNDS AND STABLE SALTS THEREOF The Regents of the University of Michigan (US) 2010-02-17 EP disclosed
WO-2008133635-A1 NOVEL SOLUBLE 1,4 BENZODIAZEPINE COMPOUNDS AND STABLE SALTS THEREOF THE REGENTS OF THE UNIVERSITY OF MICHIGAN (US) 2008-11-06 WO disclosed
US-20080064686-A1 Novel soluble 1,4 benzodiazepine compounds and stable salts thereof THE REGENTS OF THE UNIVERSITY OF MICHIGAN (US) 2008-03-13 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110245238-A1 Novel Soluble 1,4 Benzodiazepine Compounds and Stable Salts Thereof GABRA4, BAD, GABRA1 NR1H4 507/4885FFAR1 264/4885SMYD2 4207/4885
US-20080064686-A1 Novel soluble 1,4 benzodiazepine compounds and stable salts thereof GABRA4, BAD, GABRA1 NR1H4 507/4885FFAR1 264/4885SMYD2 4207/4885
US-20110009393-A1 Novel Soluble 1,4 Benzodiazepine Compounds and Stable Salts Thereof GABRA4, BAD, GABRA1 NR1H4 507/4885FFAR1 264/4885SMYD2 4207/4885
US-20120316105-A1 Polymyxin Derivates Useful As Antibacterial Agents NPEPPS, MDN1, PNKP NR1H4 2305/4885FFAR1 3284/4885SMYD2 4102/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.